| Conatumumab/Panitumumab Combination Metastatic Colorectal Cancer Study (NCT00630786) | Amgen | 2008-01-01 |
| A Phase I, Open-Label, Multi-center Study to Assess the Safety, Tolerability and Pharmacokinetics of AZD6244 (ARRY-142886) (NCT00600496) | AstraZeneca | 2007-12-14 |
| Laparoscopic Colorectal Surgery For Cancer- Long Term Survival (NCT00555295) | Tel-Aviv Sourasky Medical Center | 2007-12-01 |
| NGR-hTNF Administered in Combination With a Standard Oxaliplatin Based Regimen in Patients With Metastatic Colorectal Cancer (NCT00675012) | AGC Biologics S.p.A. | 2007-12-01 |
| Regional Anesthesia in Colon Rectal Surgery (NCT00684229) | The Cleveland Clinic | 2007-12-01 |
| Phase I Biomarker Study of Dietary Grape-derived Low Dose Resveratrol for Colon Cancer Prevention (NCT00578396) | University of California, Irvine | 2007-12-01 |
| Evaluation of Protein in the Urine in Patients Receiving Bevacizumab (NCT00849394) | North Texas Veterans Healthcare System | 2007-11-01 |
| Phase 1b/2 Study of AMG 655 With mFOLFOX6 and Bevacizumab for First-Line Metastatic Colorectal Cancer (NCT00625651) | Amgen | 2007-10-01 |
| Comparison Between ex Vivo and in Vivo Injection of Blue Dye in Sentinel Lymph Node Mapping for Colon Cancer (NCT00654342) | Chung-Ang University | 2007-10-01 |
| A Phase I/II Study With CEA(6D) VRP Vaccine in Patients With Advanced or Metastatic CEA-Expressing Malignancies (NCT00529984) | AlphaVax, Inc. | 2007-09-01 |
| Adjuvant Colon Cancer w/ ELOXatin®/5 FU Based Regimen: ACCELOX (NCT01310972) | King Faisal Specialist Hospital & Research Center | 2007-09-01 |
| A Study of the Perioperative Use of Cetuximab in Colon Cancer Patients (NCT00494611) | St. Luke's-Roosevelt Hospital Center | 2007-09-01 |
| Impact of a Mailed Educational Reminder on Fecal Occult Blood Testing (FOBT): A Randomized Controlled Trial (NCT00534053) | University of California, San Diego | 2007-06-01 |
| FOLFOX-4 3months Versus 6 Months and Bevacizumab as Adjuvant Therapy for Patients With Stage II/III Colon Cancer (NCT00646607) | Gruppo Italiano per lo studio dei Carcinomi dell'Apparato Digerente | 2007-06-01 |
| Follow-up After Surgery for Colon Cancer. General Practice vs. Surgical-based Follow-up? (NCT00572143) | University Hospital of North Norway | 2007-06-01 |
| Patient Navigator Project (NCT00375024) | H. Lee Moffitt Cancer Center and Research Institute | 2007-05-01 |
| An Assessment of Goal-Directed Intraoperative Fluid Management in Hand Assisted Laparoscopic Colectomy (NCT00467922) | Corewell Health West | 2007-05-01 |
| General Surgical Outcomes Quality Improvement Database (UH-SOCRATES) (NCT00622557) | University Hospitals Cleveland Medical Center | 2007-05-01 |
| Healthy Eating for Colon Cancer Prevention (NCT00475722) | University of Michigan | 2007-05-01 |
| Risk Communication Within Mexican-American Families (NCT00469339) | National Human Genome Research Institute (NHGRI) | 2007-04-27 |
| 111 Indium CHX-A DTPA Trastuzumab (Indium-Herceptin) for Imaging Breast Cancer (NCT01445054) | National Cancer Institute (NCI) | 2007-03-01 |
| Aspirin in Preventing Colorectal Cancer in Patients at Increased Risk of Colorectal Cancer (NCT00468910) | National Cancer Institute (NCI) | 2007-03-01 |
| Sentinel Node in Colon Cancer (NCT00411112) | University Hospital, Strasbourg, France | 2007-03-01 |
| Colon Cancer Prognosis After Radical Surgery (NCT00963352) | Haraldsplass Deaconess Hospital | 2007-01-01 |
| Safety Study of Recombinant NAPc2 to Prevent Tumor Progression and Metastases in Metastatic Colon Cancer (NCT00443573) | ARCA Biopharma, Inc. | 2006-12-01 |
| Analyzing the Composition of Tears to Identify Cancer (NCT00574678) | University of Arkansas | 2006-12-01 |
| Panitumumab Regimen Evaluation in Colorectal Cancer to Estimate Primary Response to Treatment (NCT00411450) | Amgen | 2006-11-01 |
| A Study of ZYC300 Administered With Cyclophosphamide Pre-Dosing (NCT00381173) | Eisai Inc. | 2006-11-01 |
| Ohio Patient Navigator Research Program (NCT01569672) | Ohio State University Comprehensive Cancer Center | 2006-11-01 |
| SPIRITT - Second-Line Panitumumab Irinotecan Treatment Trial (NCT00418938) | Amgen | 2006-11-01 |
| Partnership for Healthy Seniors (NCT00379743) | Johns Hopkins Bloomberg School of Public Health | 2006-10-01 |
| Trial of Acupuncture for Reduction of Post-Colectomy Ileus (NCT00402961) | Memorial Sloan Kettering Cancer Center | 2006-10-01 |
| Cancer Prevention and Treatment Among African American Older Adults: Treatment Trial (NCT00509444) | Johns Hopkins Bloomberg School of Public Health | 2006-10-01 |
| Magnetic Resonance Study of Liver in Chemotherapy (NCT00578838) | Memorial Sloan Kettering Cancer Center | 2006-08-01 |
| Frequency of Circulating Tumour Cells in Stage II and Stage III Colon Cancer Patients (NCT00351572) | Alberta Health services | 2006-07-01 |
| Irinotecan and Cetuximab for Colorectal Cancer as Second Line Therapy (NCT00336856) | University of Pittsburgh | 2006-06-01 |
| Chromocolonoscopy for the Detection of Flat Adenomas in Routine Colorectal Cancer Screening. (NCT00245492) | Indiana University | 2006-05-01 |
| Phase III Randomized Study of 5-FU, CoFactor, and Avastin vs. 5-FU, LV and Avastin for First-Line Colorectal Cancer. (NCT00337389) | Mast Therapeutics, Inc. | 2006-05-01 |
| Skin Toxicity Treatment in Metastatic Colorectal Cancer (mCRC) Patients Receiving Panitumumab + Irinotecan-based Therapy (NCT00332163) | Amgen | 2006-04-01 |
| Atorvastatin Calcium, Oligofructose-Enriched Inulin, or Sulindac in Preventing Cancer in Patients at Increased Risk of Developing Colorectal Neoplasia (NCT00335504) | National Cancer Institute (NCI) | 2006-03-01 |
| The RECHARGE Low Carbohydrate Diet Trial for Metastatic Cancer (NCT00444054) | Albert Einstein College of Medicine | 2006-02-01 |
| Molecular Profiling of Colorectal Cancer (NCT04863768) | Hellenic Cooperative Oncology Group | 2006-01-01 |
| Prognostic Molecular and Environmental Factors in High-Risk Colon Cancer Patients (NCT00354705) | M.D. Anderson Cancer Center | 2006-01-01 |
| Evaluation of NiTi Laparoscopic Compression Anastomosis Clip (LapCAC) Device for Intra-Corporeal Lap-Colectomy (NCT00250328) | Hadassah Medical Organization | 2006-01-01 |
| Placebo-Controlled Study of Perifosine + Single Agent Chemotherapy for Metastatic Cancer Patients (NCT00398879) | AEterna Zentaris | 2005-08-01 |
| A Study of Palifermin for the Reduction of Oral Mucositis in Subjects With Stage 2B or 3 Locally Advanced, Colon Cancer (NCT00393822) | Amgen | 2005-08-01 |
| Evaluation of Stool Tagging for Improved Patient Compliance (NCT00124163) | Center for Diagnostic Imaging | 2005-07-01 |
| Bevacizumab and Cetuximab in Combination With FOLFOX6 in Patients With Metastatic Colorectal Cancer (NCT00193219) | SCRI Development Innovations, LLC | 2005-07-01 |
| Promoting Physical Activity After Colorectal Cancer (NCT00230646) | The Miriam Hospital | 2005-07-01 |
| Resveratrol for Patients With Colon Cancer (NCT00256334) | University of California, Irvine | 2005-07-01 |
| Thymidylate Synthase Polymorphisms as a Predictor of Toxicity to Capecitabine Chemotherapy in Colon Cancer Treatment (NCT00126867) | AHS Cancer Control Alberta | 2005-05-01 |
| Clinical Trial in Patients With Metastatic Colorectal Cancer (NCT00235898) | Mast Therapeutics, Inc. | 2005-05-01 |
| A Randomized Trial of Cancer Risk and Health Education in Relatives of Colorectal Cancer Patients (NCT00188305) | University Health Network, Toronto | 2005-01-01 |
| Multiple Minor Hepatectomies Versus Major or Extended Hepatectomies for Colorectal Liver Metastases. (NCT02331641) | University of Milan | 2005-01-01 |
| Safety of AMG 706 Plus Panitumumab Plus Chemotherapy in the Treatment of Subjects With Metastatic Colorectal Cancer (NCT00101894) | Amgen | 2004-12-01 |
| Hepatic Arterial Infusion With Floxuridine and Dexamethasone Combination With Chemotherapy With/Without Bevacizumab for Hepatic Metastases From Colorectal Cancer (NCT00200200) | Memorial Sloan Kettering Cancer Center | 2004-11-19 |
| Phase I/II Study of Celebrex and EPO906 in Patients With Metastatic Colorectal Cancer (NCT00159484) | University of Southern California | 2004-10-12 |
| Study of D-Methadone in Patients With Chronic Pain (NCT00588640) | Memorial Sloan Kettering Cancer Center | 2004-10-01 |
| Follow-Up Study of Subjects Previously Enrolled in Poxviral Vector Gene Transfer Studies (NCT00451022) | National Cancer Institute (NCI) | 2004-09-13 |
| Molecular Genetic and Pathological Studies of Anal Tumors (NCT00267787) | Stanford University | 2004-09-01 |
| Establishing Novel Detection Techniques for Various Genetic-Related Diseases by Applying DHPLC Platform. (NCT00154960) | National Taiwan University Hospital | 2004-06-01 |
| Phase II Trial of Stereotactic Radiosurgery Boost Following Surgical Resection for Brain Metastases (NCT00587964) | Memorial Sloan Kettering Cancer Center | 2004-06-01 |
| The Significance of Sentinel Node Analysis in Colon Cancer (NCT00419978) | Legacy Health System | 2004-06-01 |
| Clinical Trial in Patients With Metastatic Colorectal Cancer (NCT00081627) | Mast Therapeutics, Inc. | 2004-04-01 |
| Capecitabine and Gemcitabine in Patients With Metastatic Colorectal Cancer (NCT00159445) | University of Southern California | 2004-03-01 |
| Pharmacokinetic and Pharmacodynamic Study of S-1 in Patients With Digestive Organ Cancer (NCT00197431) | Hamamatsu University | 2004-01-01 |
| Weekly Topotecan in Patients Treated for Metastatic Colorectal Cancer (NCT00193167) | SCRI Development Innovations, LLC | 2004-01-01 |
| Assessment of Health Related Quality of Life in Patients Treated for Rectal Cancer (NCT00532987) | Stanford University | 2003-12-01 |
| Dose-Escalation Study in Advanced Colon Cancer Patients (NCT00969046) | Novartis Pharmaceuticals | 2003-11-01 |
| Trial for Microarray Analysis of Colon Cancer Outcome-A (MACCO-A) (NCT00127036) | H. Lee Moffitt Cancer Center and Research Institute | 2003-10-01 |
| Preventive Health Behavior in Women (NCT00723996) | University of Michigan | 2003-09-01 |
| Screening for Gynecologic Cancers in Hereditary Nonpolyposis Colorectal Cancer (HNPCC) Patients (NCT00508846) | M.D. Anderson Cancer Center | 2003-05-01 |
| Cellular Immune Augmentation in Colon and Rectal Cancer (NCT00257322) | University of California, Irvine | 2003-04-01 |
| Survivin Peptide Vaccination for Patients With Advanced Melanoma, Pancreatic, Colon and Cervical Cancer (NCT00108875) | Julius-Maximilians University | 2003-04-01 |
| Performance of the Water-Enema Computed Tomography (WE-CT) (NCT00188110) | University Hospital, Angers | 2003-03-01 |
| Chemotherapy Administered Every 2 Weeks With or Without Pegfilgrastim in Subjects With Advanced or Metastatic Colon Cancer (NCT00094809) | Amgen | 2003-02-01 |
| Effects of Malnutrition on Colon Cancer Patients With Abdominal Surgery (NCT00622999) | Insel Gruppe AG, University Hospital Bern | 2003-01-01 |
| A Prospective Randomized Study Comparing Sentinel Lymph Node (SLN) Evaluation With Standard Pathological Evaluation for the Staging of Colon Carcinoma (NCT01623258) | Walter Reed Army Medical Center | 2002-12-01 |
| Study of Xeloda and Gleevec in Patients With Advanced Solid Tumors (NCT00183833) | University of Southern California | 2002-12-01 |
| Study Evaluating Isovorin in Colon Cancer (NCT00195585) | Wyeth is now a wholly owned subsidiary of Pfizer | 2002-10-01 |
| Thymidylate Synthase Polymorphisms as a Predictor of Toxicity to 5-Fluorouracil Based Chemotherapy in Stage III Colon Cancer (NCT00131599) | AHS Cancer Control Alberta | 2002-08-01 |
| Collection of Blood From Patients With Cancer (NCT00034216) | National Cancer Institute (NCI) | 2002-07-16 |
| Combined Colon and Endometrial Cancer Screening in Women With HNPCC (NCT00510796) | M.D. Anderson Cancer Center | 2002-03-01 |
| Hepatic Arterial Infusion With Floxuridine and Dexamethasone in Combination With Intravenous Oxaliplatin Plus Irinotecan in Patients With Unresectable Hepatic Metastases From Colorectal Cancer (NCT00695201) | Memorial Sloan Kettering Cancer Center | 2000-08-01 |
| Ascertainment of Families for Genetic Studies of Familial Lymphoproliferative Disorders (NCT00582621) | Memorial Sloan Kettering Cancer Center | 2000-07-01 |
| Vaccine Therapy in Treating Patients With Metastatic Cancer (NCT00020267) | National Cancer Institute (NCI) | 2000-07-01 |
| Germline Alterations of Tumor Susceptibility Genes in New York Cancer Patients (NCT00579514) | Memorial Sloan Kettering Cancer Center | 2000-03-01 |
| Celecoxib to Prevent Colorectal Cancer in Patients Who Have Undergone Surgery to Remove Polyps (NCT00005094) | National Cancer Institute (NCI) | 2000-03-01 |
| Laparoscopic Versus Open Left Colonic Resection (NCT00894725) | Università Vita-Salute San Raffaele | 2000-02-01 |
| Safety Study of hMN14 to Treat Either Colorectal or Breast Cancer (NCT00041652) | Gilead Sciences | 2000-02-01 |
| Chemoprevention With Folic Acid (NCT00018551) | US Department of Veterans Affairs | 1998-10-01 |
| Spectroscopy With Surface Coils and Decoupling (NCT00581815) | Memorial Sloan Kettering Cancer Center | 1997-02-01 |
| Antineoplaston Therapy in Treating Patients With Metastatic or Unresectable Colon Cancer (NCT00003485) | Burzynski Research Institute | 1996-04-10 |
| Cancer Control Following Polypectomy (NCT00591279) | Memorial Sloan Kettering Cancer Center | 1981-02-01 |
| Evaluation of the Proliferative Activities of Insulin Analogues in Primary Human Tumor Cells (NCT01267461) | Meir Medical Center | |
| Expanded Access for the Treatment of Cancers With Rearranged During Transfection (RET) Activation (NCT03906331) | Eli Lilly and Company | |